Publication

Article

Pharmacy Practice in Focus: Health Systems

January 2019
Volume8
Issue 1

Progress in Treating Advanced Melanoma: Pharmacists

In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).

FACULTY:

LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, Clinical Associate Professor, University of South Carolina College of Pharmacy, Columbia, South Carolina

EDUCATIONAL OBJECTIVES:

At the completion of this activity, the participant will be able to:

  • Identify the treatment options for patients with advanced melanoma
  • Examine the latest clinical data for patients with advanced melanoma
  • Explain the role of the pharmacist in supporting optimal treatment strategies in advanced melanoma management

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: December 28, 2018

EXPIRATION DATE: January 12, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs